Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    February 2021
  1. WEINER JS
    Enjoy the Vase.
    JAMA. 2021;325:629.
    PubMed    


    January 2021
  2. JAKLEVIC MC
    Imaging Drug for Prostate Cancer.
    JAMA. 2021;325:214.
    PubMed    


    November 2020
  3. ALDUBAYAN SH, Conway JR, Camp SY, Witkowski L, et al
    Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
    JAMA. 2020;324:1957-1969.
    PubMed     Abstract available


  4. FEERO WG
    Bioinformatics, Sequencing Accuracy, and the Credibility of Clinical Genomics.
    JAMA. 2020;324:1945-1947.
    PubMed    


  5. DEKA R, Courtney PT, Parsons JK, Nelson TJ, et al
    Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.
    JAMA. 2020;324:1747-1754.
    PubMed     Abstract available


  6. SHEN X, Pettaway CA, Chen RC
    Active Surveillance for Black Men With Low-Risk Prostate Cancer.
    JAMA. 2020;324:1733-1734.
    PubMed    


    October 2020
  7. SLOMSKI A
    No Mortality Differences Among Localized Prostate Cancer Treatments.
    JAMA. 2020;324:1599.
    PubMed    


    June 2020
  8. SLOMSKI A
    Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder.
    JAMA. 2020;323:2453.
    PubMed    


  9. PARSONS JK, Pierce JP, Marshall JR
    Vegetable Consumption and Progression of Prostate Cancer-Reply.
    JAMA. 2020;323:2530.
    PubMed    


  10. CSIZMADI I, Lin PH, Freedland SJ
    Vegetable Consumption and Progression of Prostate Cancer.
    JAMA. 2020;323:2529-2530.
    PubMed    


  11. KERLEY CP
    Vegetable Consumption and Progression of Prostate Cancer.
    JAMA. 2020;323:2528-2529.
    PubMed    


    May 2020
  12. ABBASI J
    PET-CT Improved High-risk Prostate Cancer Staging in Trial.
    JAMA. 2020;323:1764.
    PubMed    


    January 2020
  13. HOFFMAN KE, Penson DF, Zhao Z, Huang LC, et al
    Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.
    JAMA. 2020;323:149-163.
    PubMed     Abstract available


  14. PARSONS JK, Zahrieh D, Mohler JL, Paskett E, et al
    Effect of a Behavioral Intervention to Increase Vegetable Consumption on Cancer Progression Among Men With Early-Stage Prostate Cancer: The MEAL Randomized Clinical Trial.
    JAMA. 2020;323:140-148.
    PubMed     Abstract available


    December 2019
  15. RUBIN R
    Assessing Whether Infertile Men Have a Higher Risk of Prostate Cancer.
    JAMA. 2019 Dec 4. pii: 2757280. doi: 10.1001/jama.2019.19203.
    PubMed    


    October 2019
  16. ABBASI J
    Gold Nanoshells Ablate Prostate Tumors.
    JAMA. 2019;322:1343.
    PubMed    


    September 2019
  17. HAMPTON T
    Compound in Broccoli Restores Tumor Suppressor Activity.
    JAMA. 2019;322:805-806.
    PubMed    


    May 2019
  18. MAHAL BA, Huang FW
    Racial Disparities in Low-Risk Prostate Cancer-Reply.
    JAMA. 2019;321:1727-1728.
    PubMed    


  19. EHDAIE B, Carlsson S, Vickers A
    Racial Disparities in Low-Risk Prostate Cancer.
    JAMA. 2019;321:1726-1727.
    PubMed    


  20. POLITE BN, Gluck AR, Brawley OW
    Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
    JAMA. 2019;321:1663-1664.
    PubMed    


    April 2019
  21. WYNER LM
    Artist, Rediscovered: Images and Ethics of Early Prostate Cancer Screening.
    JAMA. 2019;321:1236-1238.
    PubMed    


    February 2019
  22. MAHAL BA, Butler S, Franco I, Spratt DE, et al
    Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.
    JAMA. 2019 Feb 11. pii: 2724897. doi: 10.1001/jama.2018.19941.
    PubMed    


    December 2018
  23. MAHAL BA, Berman RA, Taplin ME, Huang FW, et al
    Prostate Cancer-Specific Mortality Across Gleason Scores in Black vs Nonblack Men.
    JAMA. 2018;320:2479-2481.
    PubMed    


    August 2018
  24. MARTIN RM
    Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention-Reply.
    JAMA. 2018;320:600-601.
    PubMed    


  25. PINSKY PF
    Power of a Trial Investigating a Low-Intensity PSA-Based Screening Intervention.
    JAMA. 2018;320:600.
    PubMed    


    July 2018
  26. KISHAN AU, Cook RR, King CR
    Optimal Treatment for High-Risk Prostate Cancer-Reply.
    JAMA. 2018;320:405.
    PubMed    


  27. ONG WL, Koh TL, Millar J
    Optimal Treatment for High-Risk Prostate Cancer.
    JAMA. 2018;320:404-405.
    PubMed    


    May 2018
  28. LOEB S, Byrne N, Makarov DV, Lepor H, et al
    Use of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015.
    JAMA. 2018 May 15. pii: 2681802. doi: 10.1001/jama.2018.5616.
    PubMed    


  29. FENTON JJ, Weyrich MS, Durbin S, Liu Y, et al
    Prostate-Specific Antigen-Based Screening for Prostate Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;319:1914-1931.
    PubMed     Abstract available


  30. GROSSMAN DC, Curry SJ, Owens DK, Bibbins-Domingo K, et al
    Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;319:1901-1913.
    PubMed     Abstract available


  31. JIN J
    Screening for Prostate Cancer.
    JAMA. 2018;319:1946.
    PubMed    


  32. CARTER HB
    Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence.
    JAMA. 2018;319:1866-1868.
    PubMed    


    March 2018
  33. KISHAN AU, Cook RR, Ciezki JP, Ross AE, et al
    Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
    JAMA. 2018;319:896-905.
    PubMed     Abstract available


  34. MARTIN RM, Donovan JL, Turner EL, Metcalfe C, et al
    Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
    JAMA. 2018;319:883-895.
    PubMed     Abstract available


  35. BARRY MJ
    Screening for Prostate Cancer: Is the Third Trial the Charm?
    JAMA. 2018;319:868-869.
    PubMed    


    December 2017
  36. MATULEWICZ RS, Weiner AB, Schaeffer EM
    Active Surveillance for Prostate Cancer.
    JAMA. 2017;318:2152.
    PubMed    


    June 2017
  37. LITWIN MS, Tan HJ
    The Diagnosis and Treatment of Prostate Cancer: A Review.
    JAMA. 2017;317:2532-2542.
    PubMed     Abstract available


    April 2017
  38. BIBBINS-DOMINGO K, Grossman DC, Curry SJ
    The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment.
    JAMA. 2017 Apr 11. doi: 10.1001/jama.2017.4413.
    PubMed    


    March 2017
  39. BAROCAS DA, Alvarez J, Resnick MJ, Koyama T, et al
    Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years.
    JAMA. 2017;317:1126-1140.
    PubMed     Abstract available


  40. CHEN RC, Basak R, Meyer AM, Kuo TM, et al
    Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer.
    JAMA. 2017;317:1141-1150.
    PubMed     Abstract available


  41. HAMDY FC, Donovan JL
    Patient-Reported Outcomes Following Treatment for Localized Prostate Cancer: Helping Decision Making for Patients and Their Physicians.
    JAMA. 2017;317:1121-1123.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: